Not only is there a change on the energy expenditure side, but also on the intake side
For example, Ozempics FDA label was expanded in September 2023, shortly after the first lawsuits were filed, to include ileus as a possible gastrointestinal disorder
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials
Int J Mol Sci (2017) 18(7):1583
The WHO added the three GLP-1 medicines that have been approved by stringent medicine regulators to its essential drug list liraglutide, semaglutide and tirzepatide
SWMPs must clearly define their value in the evolving weight loss landscape, particularly as GLP-1 therapies become more prevalent